Synaptrix
Pre-clinicalIntroducing Neuralis by Synaptrix Labs, the first device that allows paralyzed patients to move their wheelchairs through brain activity alone, powered by our novel AI based EEG signal processing model that makes it possible.
Founded
2020
Focus
NeuroscienceAI / Machine Learning
About
Introducing Neuralis by Synaptrix Labs, the first device that allows paralyzed patients to move their wheelchairs through brain activity alone, powered by our novel AI based EEG signal processing model that makes it possible.
Funding History
1Total raised: $4.5M
Seed$4.5MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2020
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile